Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement

Digestion

Volumn 85, Issue 3, 2012, Pages 219-227

  Kim, Beom Kyung ^a   Park, Young Nyun ^a   Kim, Do Young ^a,b   Park, Jun Yong ^a,b   Chon, Chae Yoon ^a,b,c   Han, Kwang Hyub ^a   Ahn, Sang Hoon ^a  

^a Yonsei University   (South Korea)

^b Liver Cirrhosis Clinical Research Center   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Chronic hepatitis B; Decompensation; Liver cirrhosis; Liver stiffness measurement; Prediction

Indexed keywords

ADULT; ARTICLE; ASCITES; DECOMPENSATED LIVER CIRRHOSIS; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ASCITES; ELASTICITY IMAGING TECHNIQUES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATIC INSUFFICIENCY; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84862828302     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000335430     Document Type: Article

References (31)

1. Han KH, Yoon KT New diagnostic method for liver fibrosis and cirrhosis. Intervirology 2008; 51(suppl 1):11-16 (Pubitemid 351821837)
2. Cadranel JF, Rufat P, Degos F: Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481
3. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008; 48(suppl 1):S68-S92
4. Thalheimer U, Mela M, Patch D, Burroughs AK: Targeting portal pressure measurements: a critical reappraisal. Hepatology 2004; 39: 286-290 (Pubitemid 38222166)
5. Smith JO, Sterling RK: Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Ther 2009; 30: 557-576
6. Castera L, Forns X, Alberti A: Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-847
7. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, Petrarca A, Moscarella S, Belli G, Zignego AL, Marra F, Laffi G, Pinzani M: Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297 (Pubitemid 46775793)
8. Kazemi F, Kettaneh A, N'Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, Beaugrand M: Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45: 230-235
9. Castera L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, Couzigou P, de Lédinghen V: Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009; 50: 59-68
10. Kim BK, Han KH, Park JY, Ahn SH, Kim JK, Paik YH, Lee KS, Chon CY, Kim Do Y: A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol 2010; 105: 1382-1390
11. Kim BK, Kim DY, Han KH, Park JY, Kim JK, Paik YH, Lee KS, Chon CY, Ahn SH: Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. Am J Gastroenterol 2011; 106: 1654-1662
12. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The Metavir Cooperative Study Group. Hepatology 1996; 24: 289-293 (Pubitemid 26260021)
13. Dittrich M, Milde S, Dinkel E, Baumann W, Weitzel D: Sonographic biometry of liver and spleen size in childhood. Pediatr Radiol 1983; 13: 206-211 (Pubitemid 13069001)
14. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Lédinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M: Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54 (Pubitemid 40066382)
15. Heagerty PJ, Lumley T, Pepe MS: Time-dependent roc curves for censored survival data and a diagnostic marker. Biometrics 2000; 56: 337-344 (Pubitemid 30422619)
16. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871 (Pubitemid 30169932)
17. Fluss R, Faraggi D, Reiser B: Estimation of the Youden index and its associated cutoff point. Biom J 2005; 47: 458-472 (Pubitemid 41229379)
18. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J: Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133: 481-488 (Pubitemid 47187350)
19. Robic MA, Procopet B, Metivier S, Peron JM, Selves J, Vinel JP, Bureau C: Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol 2011; 55: 1017-1024
20. Rockey DC: Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008; 134: 8-14 (Pubitemid 350309358)
21. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, Mele MR, Testa E, Mansi C, Savarino V, Testa R: Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003; 52: 1200-1205 (Pubitemid 36877436)
22. Giannini EG: Thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther 2006; 23: 1055-1065 (Pubitemid 43779344)
23. Poynard T, Trabut JB, Ratziu V, Thabut D: Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone. Gut 2004; 53: 913-914
24. Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, Cho SW, Han KH, Chon CY, Moon YM, Ahn SH: Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver international 2007; 27: 969-976 (Pubitemid 47261951)
25. Kim BK, Han KH, Park JY, Ahn SH, Kim JK, Paik YH, Lee KS, Chon CY, Kim do Y: Prospective validation of p2/ms noninvasive index using complete blood counts for detecting oesophageal varices in b-viral cirrhosis. Liver International 2010; 30: 860-866
26. Kim BK, Han KH, Park JY, Ahn SH, Chon CY, Kim JK, Paik YH, Lee KS, Park YN, Kim do Y: A novel liver stiffness measurementbased prediction model for cirrhosis in hepatitis B patients. Liver Int 2011; 30: 1073-1081
27. Lok AS, McMahon BJ: Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662
28. Wiegand J, van Bommel F, Berg T: Management of chronic hepatitis B: status and challenges beyond treatment guidelines. Semin Liver Dis 2010; 30: 361-377
29. European Association for the Study of the Liver: EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-242
30. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008; 2: 263-283
31. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J: Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 1521-1531.